Skip to main content
ESTA
NASDAQ Industrial Applications And Services

Establishment Labs Lifts Full-Year Outlook as Q2 Revenue Surges 32%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$90.82
Mkt Cap
$2.686B
52W Low
$33.35
52W High
$97.59
52W Position info
172% above low
Off High info
6.9% below high
Rel. Volume info
1.5× avg
Market data snapshot near publication time

ESTA has more than doubled off its 52-week low of $33.35.

Summary

Establishment Labs reported Q2 2026 revenue of $67.5 million, up 31.7% year-over-year, and raised full-year guidance to $269–$271 million. Adjusted EBITDA turned positive at $3.7 million, and cash improved to $71.2 million.

Updates

  1. · SEC 10-Q — The 10-Q discloses a $300 million Oaktree facility refinancing and notes payable of $261.7 million as of June 30, 2026.

  2. · Reuters — EPS was $0.39, below the $0.34 consensus, while adjusted expenses rose only 2%.


Key Events · Earnings and Guidance · ESTA

  • Q2 Revenue Beats, Up 32%

    Revenue reached $67.5 million, a 31.7% increase from Q2 2025, driven by U.S. sales of $24.7 million (up 26% sequentially) and minimally invasive platform revenue of $12.1 million.

  • Full-Year Guidance Raised

    Management lifted 2026 revenue guidance to $269–$271 million from the prior $266.5–$268.5 million, implying continued strong growth in the second half.

  • Adjusted EBITDA Turns Positive

    Adjusted EBITDA improved to $3.7 million from a loss of $8.5 million a year ago, reflecting operating leverage as revenue scales.

  • Cash Position Strengthens

    Cash balance rose to $71.2 million as of June 30, 2026, up $3.1 million from Q1 2026 and $16.5 million from the year-ago period.


Analysis · ESTA · Industrial Applications And Services

A strong second quarter saw revenue climb 31.7% to $67.5 million, topping consensus estimates and underscoring the momentum behind the company's minimally invasive breast aesthetics platform. Reflecting that confidence, management raised full-year 2026 revenue guidance to $269–$271 million. Adjusted EBITDA swung to a $3.7 million profit from a year-ago loss, while the cash balance improved sequentially to $71.2 million. The results mark a clear inflection toward profitability and cash generation, reinforcing the growth narrative.

How filings like this one have moved

In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, ESTA was trading at $90.82 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $2.7B. The 52-week trading range was $33.35 to $97.59. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ESTA - Latest Insights

ESTA
Oct 29, 2026, 8:25 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $68.00
Real-time Price: $69.79 info
Change: +$1.78 (+3%) info
Market Cap: $2.086B info
ESTA
Oct 29, 2026, 8:05 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $68.00
Real-time Price: $69.79 info
Change: +$1.78 (+3%) info
Market Cap: $2.086B info
ESTA
Oct 05, 2026, 8:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $64.20
Real-time Price: $69.79 info
Change: +$5.58 (+9%) info
Market Cap: $2.086B info
ESTA
Aug 07, 2026, 4:06 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $77.42
Real-time Price: $69.79 info
Change: -$7.64 (-10%) info
Market Cap: $2.086B info
ESTA
Aug 06, 2026, 8:10 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $91.18
Real-time Price: $69.79 info
Change: -$21.40 (-23%) info
Market Cap: $2.086B info